IDEntifying PAtients with Suspicion of Infection in the ED Who Have Low Disease Severity Using Midregional Proadrenomedullin (MR-proADM) – A Pragmatic Pivotal Randomized Controlled Trial

Kordo Saeed(University Hospital Southampton NHS Foundation Trust), Juan González del Castillo(Hospital Clínico San Carlos), Ana Alonso Morilla(Hospital Universitario Central de Asturias), María T. Abreu(Icahn School of Medicine at Mount Sinai), Pablo Herrero(Hospital Universitario Central de Asturias), Robert Crouch(University Hospital Southampton NHS Foundation Trust), V. Rodríguez(Anderson Hospital), Pierre Hausfater(Inserm), Nathan W. Moore(Sandia National Laboratories California), Emanuela Sozio(Azienda Unità Sanitaria Locale di Ferrara), Carlota Clemente-Callejo(Hospital Clínico San Carlos), Ahilanandan Dushianthan(University Hospital Southampton NHS Foundation Trust), Manuel Morales‐Ruiz(Universitat de Barcelona), Jacopo M. Legramante(University of Rome Tor Vergata), Ralf Jäger(Scientific Fishery Systems (United States)), Andrej Schwabe(AGCO (Netherlands)), Marilena Minieri, Carlo Tascini(Ospedale D. Cotugno), Tristan Clark(National Institute for Health and Care Research), Jérôme Alexandre Denis(Sorbonne Université), Albert Quartermain(University Hospital Southampton NHS Foundation Trust), Catalina Sánchez Mora(Hospital Universitario Virgen Macarena), Enrique del Toro(Hospital Clínico San Carlos), Alfredo Giovannelli(University of Rome Tor Vergata), Carmen Navarro(Hospital Universitario Virgen Macarena), Stefan Ebmeyer(University of Gothenburg)
SSRN Electronic Journal
January 1, 2025
Cited by 0


Related Papers